Keywords: Alcon, Novartis, M&A,

Alcon Independent Director Committee slams Novartis offer as “grossly inadequate, offensive and disrespectful”

Article | 21 January 2010

Print This

Responding formally to Swiss drug major Novartis’ offer to buy the global eye-care leader (The Pharma Letter June 4), the Independent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in